Allos is a technology company leveraging causal AI to transform pharmaceutical development and biomanufacturing. The company develops a closed-loop system that simulates how interventions affect outcomes, enabling the definition of a robust operating window before experiments are conducted. This system learns from every run and deviation, serving as a single source of truth with traceable drivers, documented assumptions, and controlled version history. Allos combines deep expertise in causal AI engineering with decades of experience in GMP, tech transfer, and CDMO operations, delivering explainable, auditable, and compliant AI solutions for life sciences.